BriaCell Therapeutics Stock Quote BCT - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

10.60

Bid

10.50

Ask

11.05

Volume

0.00 Day's Range 0.00

10.60 52 Week Range 10.60

Market Cap

193.81M

Previous Close

10.60

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

18,284,000

Dividend Yield

PE Ratio

-40.44

Earnings Per Share (EPS)

-0.26

Revenue

Net Profit

-4.79M

Sector

Aircraft

Industry

Business Services, Nec

Website

www.briacell.com

Headquarters

Vancouver, British Columbia, Can

Founded

2009

BriaCell Therapeutics Corp is listed in the Aircraft sector of the TSX Venture Exchange with ticker BCT. The last closing price for BriaCell Therapeutics was $10.60. Over the last year, BriaCell Therapeutics shares have traded in a share price range of $ 10.60 to $ 10.60.

BriaCell Therapeutics currently has 18,284,000 shares outstanding. The market capitalization of BriaCell Therapeutics is $193.81 million. BriaCell Therapeutics has a price to earnings ratio (PE ratio) of -40.44.

BriaCell Announces Rescheduling of its Annual General Meeting of Shareholders to February 5, 2025

PHILADELPHIA and VANCOUVER, British Columbia, Jan. 03, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage...

BriaCell Adds Two Clinical Trial Sites to Accelerate Patient Enrollment

PHILADELPHIA and VANCOUVER, British Columbia, Feb. 28, 2022 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage...

BriaCell Appoints Leading Immunologist Dr. Alexander Kharazi to its Scientific Advisory Board

PHILADELPHIA and VANCOUVER, British Columbia, Feb. 23, 2022 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage...

BriaCell Appoints Renowned Oncologist, Giuseppe Del Priore, MD, MPH, as Chief Medical Officer

PHILADELPHIA and VANCOUVER, British Columbia, Feb. 16, 2022 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage...

BriaCell to Present at the AACR 2022; Provides Corporate Buyback and Insider Buying Update

BriaCell selected to present at the American Association for Cancer Research (AACR) Annual Meeting 2022Corporate buyback program continues; 1,031,672 shares and 200,740 warrants repurchased since...

BriaCell Therapeutics Corp. Announces Results of 2022 Annual and Special Meeting of Shareholders

NEW YORK and VANCOUVER, British Columbia, Jan. 19, 2022 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), is pleased to announce...

BriaCell to Uplist and Trade on the Toronto Stock Exchange from TSX Venture Exchange under 'BCT'; Remains 'BCTX' on Nasdaq

BERKELEY, Calif. and VANCOUVER, British Columbia, Dec. 29, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage...

BriaCell Announces Insiders’ Intention to Purchase up to 10% of Public Market Securities

Insiders intend to acquire up to approximately 10% of BriaCell’s basic common shares, or 1.59 million sharesCorporate buyback program will continue; 501,703 shares and 143,236 warrants repurchased...

BriaCell Summarizes Clinical Data Poster Presented at the 2021 San Antonio Breast Cancer Symposium®

NEW YORK and VANCOUVER, British Columbia, Dec. 09, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) (“BriaCell” or the “Company”), a clinical-stage...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	10.6	10.6	10.6	0	0	CS
4	0	0	10.6	10.6	10.6	0	0	CS
12	0	0	10.6	10.6	10.6	0	0	CS
26	0	0	10.6	10.6	10.6	0	0	CS
52	0	0	10.6	10.6	10.6	0	0	CS
156	0	0	10.6	10.6	10.6	0	0	CS
260	-1.38	-11.5191986644	11.98	27	3.5	2655	7.78591699	CS

BCT - Frequently Asked Questions (FAQ)

What is the current BriaCell Therapeutics share price?

The current share price of BriaCell Therapeutics is $ 10.60

How many BriaCell Therapeutics shares are in issue?

BriaCell Therapeutics has 18,284,000 shares in issue

What is the market cap of BriaCell Therapeutics?

The market capitalisation of BriaCell Therapeutics is CAD 193.81M

What is the 1 year trading range for BriaCell Therapeutics share price?

BriaCell Therapeutics has traded in the range of $ 10.60 to $ 10.60 during the past year

What is the PE ratio of BriaCell Therapeutics?

The price to earnings ratio of BriaCell Therapeutics is -40.44

What is the reporting currency for BriaCell Therapeutics?

BriaCell Therapeutics reports financial results in USD

What is the latest annual profit for BriaCell Therapeutics?

The latest annual profit of BriaCell Therapeutics is USD -4.79M

What is the registered address of BriaCell Therapeutics?

The registered address for BriaCell Therapeutics is SUITE 300 - 235 WEST 15TH STREET, VANCOUVER, BRITISH COLUMBIA, V7T 2X1

What is the BriaCell Therapeutics website address?

The website address for BriaCell Therapeutics is www.briacell.com

Which industry sector does BriaCell Therapeutics operate in?

BriaCell Therapeutics operates in the BUSINESS SERVICES, NEC sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SQGSpackman Equities Group Inc	$ 2.50 (224.68%)	41.15k
GNFIGenifi Inc	$ 0.01 (100.00%)	2k
XBOTRealbotix Corp	$ 0.54 (63.64%)	3.71M
ADDArctic Star Exploration Corp	$ 0.015 (50.00%)	1.02M
EBMEastwood Bio Medical Canada Inc	$ 0.70 (41.41%)	500
ETUE2gold Inc	$ 0.005 (-50.00%)	11.29k
ENTGEntourage Health Corp	$ 0.005 (-50.00%)	16.04k
MNCMagnetic North Aquisition Corp	$ 0.06 (-36.84%)	34.04k
MTHMammoth Resources Corp	$ 0.01 (-33.33%)	54k
KSKlondike Silver Corp	$ 0.01 (-33.33%)	102k
XBOTRealbotix Corp	$ 0.54 (63.64%)	3.71M
RHCRoyal Helium Ltd	$ 0.02 (0.00%)	3.38M
GPUSAlset AI Ventures Inc	$ 0.195 (-7.14%)	3.18M
THRMTherma Bright Inc	$ 0.04 (-20.00%)	2.41M
QNCQuantum Emotion Corp	$ 1.06 (-5.36%)	2.2M